Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Adenosine complex helps increase hair thickness and density in hair loss.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Most women with female pattern hair loss have low vitamin D levels.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.